--- title: "Dow 30 Earnings: Procter & Gamble Third Quarter Fiscal 2017" description: dow 30 earnings, procter & gamble, blue chip stock may offer limited long-term capital appreciation potential, organic revenues will pick up 2% and 3% year image: https://investor.valueline.com/hubfs/VL%20Blog%20Images/iStock-186324219.jpg --- [![The Value Line Blog](https://investor.valueline.com/hubfs/VL%20Blog%20Images/vl_blog_header.png)](https://investor.valueline.com/blog) [Stock Highlights](https://investor.valueline.com/blog/topic/stock-highlights) # Dow 30 Earnings: Procter & Gamble Third Quarter Fiscal 2017 April 26, 2017 Consumer goods conglomerate **Procter & Gamble** ([PG](https://research.valueline.com/research#sec=company&sym=PG)- [Free P&G Stock Report](https://research.valueline.com/api/report?documentID=2185-VL_20170324_VLIS_PG_2211_01-24L5HJ1UIEEV0PB78JL42II436&symbol=PG)) reported mixed fiscal third-quarter results (year ends June 30th). And the stock price was down slightly in recent market action. Earnings per share increased 12% year over year, coming in at $0.96, two pennies ahead of our estimate. But, revenues slipped about 1%, to $15.6 billion (just shy of our $15.8 billion call). The company has continued to face market headwinds, currency drag and geopolitical interruptions overshadowed its overseas business. And even though increased shipping volume helped bolster organic sales, the impact of minor brand divestitures offset the gains from an improved pricing and product mix. Indeed, during the March quarter, the company experienced top-line weakness in all of its categories save for the health care segment. Earnings, on the other hand, benefited from P&G's ongoing restructuring efforts. And we imagine cost-cutting initiatives and productivity enhancements will bolster operating margins moving forward. Meanwhile, the company has boosted shareholder returns. It repurchased about $2 billion of common stock over the past quarter. Plus, the board of directors raised the quarterly dividend 3%, to $0.6896. Management expects organic revenues will pick up between 2% and 3% this year. In addition, online sales compose about 5% of the top line. And the company may well pursue e-commerce growth to better diversify its revenue streams. However, the aforementioned challenges, including an unfavorable foreign currency exchange environment will likely cause total revenues to slip again in fiscal 2017. In all, we look for the top line to recede about 2% for the full year. Earnings are liable to climb at a mid- to upper-single digit clip in fiscal 2017. The company's recent streamlining measures, and increased operating efficiency, should continue to lift totals in the coming quarters. What's more, stock buybacks ought to bolster per-share comparisons. We have raised our full-year bottom-line estimate by a nickel, to $3.90 a share. This blue chip stock may offer limited long-term capital appreciation potential. But it possesses sterling scores for Safety (1) and Financial Strength (A++), and a low Beta (.70), adding to its conservative appeal. Plus, with the recent dividend increase, the stock will likely appeal to investors seeking healthy risk-adjusted income equities. **About The Company: **The Procter & Gamble Company makes detergents, soaps, toiletries, foods, paper, & industrial products. Brands include: *Head & Shoulders, Olay, Pantene, SK-II, Wella, Fusion, Gillette, Mach 3, Presobarba, Crest, Oral-B, Vicks, Ariel, Dawn, Downy, Febreze, Gain, Tide, Always, Bounty, Charmin,* and *Pampers.* *At the time of this article’s writing, the author did not have positions in any of the companies mentioned.* [![Register now for our free One Stock to Buy webinar](https://no-cache.hubspot.com/cta/default/2532383/5a80130b-f0ce-4bd8-acbd-f077f2232ec5.png)](https://cta-redirect.hubspot.com/cta/redirect/2532383/5a80130b-f0ce-4bd8-acbd-f077f2232ec5) ### Popular Posts Search Search Blog ### Topics - [Investing 101 (2)](https://investor.valueline.com/blog/topic/investing-101) - [Market Commentary (37)](https://investor.valueline.com/blog/topic/market-commentary) - [Stock Highlights (390)](https://investor.valueline.com/blog/topic/stock-highlights) - [Stock Market Today (2071)](https://investor.valueline.com/blog/topic/stock-market-today) Copyright 2026 Value Line, Inc. All Rights Reserved. Factual material is obtained from sources believed to be reliable and is provided without warranties of any kind. VALUE LINE IS NOT RESPONSIBLE FOR ANY ERRORS OR OMISSIONS HEREIN OR ANY DAMAGES OR LOSSES ARISING FROM ANY USE OF THE INFORMATION CONTAINED HEREIN. This blog is strictly for subscriber's own, non-commercial, internal use. No part of it may be reproduced, stored or transmitted in any printed, electronic or other form, or used for generating or marketing any printed or electronic publication, service or product. Officers, directors, or employees of Value Line, Inc. and its affiliates and subsidiaries, and EULAV Asset Management, may own stocks that are featured in this email. Nothing herein should be construed as an offer to buy or sell securities or to give individual investment advice. Value Line, the Value Line logo, The Most Trusted Name in Investment Research, “Smart research. Smarter investing.”, The Value Line Investment Survey, Timeliness, and Safety are trademarks or registered trademarks of Value Line, Inc. and/or its affiliates in the United States and other countries.